These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 28199360)
1. Systematic review of statistically-derived models of immunological response in HIV-infected adults on antiretroviral therapy in Sub-Saharan Africa. Sempa JB; Ujeneza EL; Nieuwoudt M PLoS One; 2017; 12(2):e0171658. PubMed ID: 28199360 [TBL] [Abstract][Full Text] [Related]
2. Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models. Sempa JB; Rossouw TM; Lesaffre E; Nieuwoudt M PLoS One; 2019; 14(11):e0224723. PubMed ID: 31721805 [TBL] [Abstract][Full Text] [Related]
3. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa. Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445 [TBL] [Abstract][Full Text] [Related]
4. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M; Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120 [TBL] [Abstract][Full Text] [Related]
5. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M; Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252 [TBL] [Abstract][Full Text] [Related]
6. High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women. Giuliano M; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Ciccacci F; Amici R; Marazzi MC; Vella S; Palombi L; Mancinelli S J Clin Virol; 2017 Nov; 96():17-19. PubMed ID: 28918126 [TBL] [Abstract][Full Text] [Related]
7. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189 [TBL] [Abstract][Full Text] [Related]
8. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment. Bwire R; Nagelkerke NJ; Borgdorff MW Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731 [TBL] [Abstract][Full Text] [Related]
9. Country of birth does not influence long-term clinical, virologic, and immunological outcome of HIV-infected children living in the Netherlands: a cohort study comparing children born in the Netherlands with children born in Sub-Saharan Africa. Cohen S; van Bilsen WP; Smit C; Fraaij PL; Warris A; Kuijpers TW; Geelen SP; Wolfs TF; Scherpbier HJ; van Rossum AM; Pajkrt D J Acquir Immune Defic Syndr; 2015 Feb; 68(2):178-85. PubMed ID: 25405830 [TBL] [Abstract][Full Text] [Related]
10. CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients. Vandormael A; Rego F; Danaviah S; Carlos Junior Alcantara L; Boulware DR; de Oliveira T Curr HIV Res; 2017; 15(3):225-231. PubMed ID: 28215175 [TBL] [Abstract][Full Text] [Related]
11. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings. Chang LW; Harris J; Humphreys E Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969 [TBL] [Abstract][Full Text] [Related]
12. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126 [TBL] [Abstract][Full Text] [Related]
13. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda. Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D; AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492 [TBL] [Abstract][Full Text] [Related]
14. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China. Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800 [TBL] [Abstract][Full Text] [Related]
15. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study. Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014 [TBL] [Abstract][Full Text] [Related]
16. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France. Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R; HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860 [TBL] [Abstract][Full Text] [Related]
17. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012. Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D; AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124 [TBL] [Abstract][Full Text] [Related]
18. Modelling immune deterioration, immune recovery and state-specific duration of HIV-infected women with viral load adjustment: using parametric multistate model. Dessie ZG; Zewotir T; Mwambi H; North D BMC Public Health; 2020 Mar; 20(1):416. PubMed ID: 32228523 [TBL] [Abstract][Full Text] [Related]
19. CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus. Bishop JD; DeShields S; Cunningham T; Troy SB Am J Med Sci; 2016 Sep; 352(3):239-44. PubMed ID: 27650226 [TBL] [Abstract][Full Text] [Related]
20. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia. Aghokeng AF; Monleau M; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Toni TD; Touré-Kane C; Truong LX; Delaporte E; Chaix ML; Peeters M; Ayouba A; Clin Infect Dis; 2014 Jan; 58(1):99-109. PubMed ID: 24076968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]